Medicinal plant raw materials in the pharmaceutical market of Kazakhstan: a comparative analysis of registered products in 2020 and 2025.

Main Article Content

Aigul Jussupkaliyeva

Astana Medical University, Astana, Kazakhstan

grmoonmate@gmail.com

Sholpan Akhelova

Astana Medical University, Astana, Kazakhstan

ahelova.sh@amu.kz

Abstract

Medicinal plant raw materials are the basis of herbal preparations in medical practice, and studying their range on the pharmaceutical market of Kazakhstan allows us to assess development trends, product expansion, and improvement of quality control standards. The aim of the study was to conduct a comparative analysis of the range, morphological groups, and composition of domestic producers of medicinal plant raw materials registered in the State Register of Medicines of the Republic of Kazakhstan in 2020 and 2025, identifying changes in the nomenclature and distribution according to the ATC (Anatomical Therapeutic Chemical) classification. Open data from the register was used, a retrospective analysis of the quantity and distribution of raw materials by morphological groups and ATC categories was carried out, and information about manufacturers was systematized with verification of botanical names in Microsoft Excel. The results showed that the total number of registered raw materials remained stable (26 items), with Zerde-Fito LLP being the main manufacturer. The emergence of new manufacturers – Daulet-Farm LLP and Karaganda Pharmaceutical Plant LLP was accompanied by the registration of previously absent species, including parmelia thalli and salt marsh grass. The ATС categories have expanded to include new therapeutic areas, and the nomenclature of some species has been refined. The market for medicinal plant raw materials in Kazakhstan remains stable in terms of quantity, while at the same time, there is a structural renewal of the product range, the emergence of new manufacturers, and harmonization of the nomenclature, reflecting the development of phytotherapy and the strengthening of the national pharmaceutical sector.

Keywords:
medicinal plants, pharmacognosy, drug industry, registries, Kazakhstan, classification

Article Details

Received 2026-02-12
Accepted 2026-04-04
Published 2026-04-06

References

Esbolatova D.E., Belgizhan A.B., Akylbek A.A., Kapsalyamova E.N. (2013) Analiz proizvodstva lekarstvennogo rastitel'nogo syr'ya v mire [Analysis of the production of medicinal plant raw materials in the world]. Vestnik KazNMU, vol. 5(3), pp. 85–88.

Salamon I. Medicinal, aromatic, and spice plants: biodiversity, phytochemistry, bioactivity, and processing innovation // Horticulturae. – 2024. – Vol. 10(3). – Article 280. https://doi.org/10.3390/horticulturae10030280.

Latif R., Nawaz T. Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications // Phytochemistry Reviews. – 2025. https://doi.org/10.1007/s11101-025-10194-7.

Stepanyan A., Ovsepyan V. (2021) Mikologicheskoe zagryaznenie lekarstvennykh rastitel'nykh sredstv [Mycological contamination of medicinal plant raw materials]. Sciences of Europe, no. 72, pp. 7–10.

Saybel O. The principle of the integrated use of plant raw materials as a tool for resource-saving technologies for obtaining therapeutic and prophylactic agents // Problems of Biological, Medical and Pharmaceutical Chemistry. – 2021. – Vol. 24(12). – P. 3–10. https://doi.org/10.29296/25877313-2021-12-01.

Gosudarstvennaya farmakopeya Rossiyskoy Federatsii. (2015) XIII izdanie, tom 2. Lekarstvennoe rastitel'noe syr'yo. Farmatsevticheskie substantsii rastitel'nogo proiskhozhdeniya [State Pharmacopoeia of the Russian Federation. XIII edition, vol. 2. Medicinal plant raw materials. Pharmaceutical substances of plant origin]. Moscow.

Wang H., Chen Y., Wang L., Liu Q., Yang S., Wang C. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices // Frontiers in Pharmacology. – 2023. – Vol. 14. – Article 1265178. https://doi.org/10.3389/fphar.2023.1265178.

Imanbayeva A.A., Gassanova G.G., Tuyakova A.T. Results of study of wild medicinal plants of Mangystau region // Fundamental and Experimental Biology. – 2020. – Vol. 3. – P. 43–53. https://doi.org/10.31489/2020bmg3/43-53.

Mikulic M. Pharmaceutical market: worldwide revenue 2001–2022 // Statista [Electronic resource]. – 2023. – Available at: https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/.

Fortune Business Insights. Impact of COVID-19 on pharmaceuticals market: pharmaceutical market size, share & growth report – 2032 [Electronic resource]. – 2025. – Available at: https://www.fortunebusinessinsights.com/impact-of-covid-19-on-pharmaceuticals-market-102685.

Natsional'nyi tsentr ekspertizy lekarstvennykh sredstv, izdelii meditsinskogo naznacheniya i meditsinskoy tekhniki. (2024) Obzor farmatsevticheskogo rynka Respubliki Kazakhstan po itogam 9 mesyatsev 2024 goda [Review of the pharmaceutical market of the Republic of Kazakhstan based on the results of 9 months of 2024] [Electronic resource]. Available at: https://aprfd.kz/index.php/novosti/item/2798-obzor-farmatsevticheskogo-rynka-respubliki-kazakhstan-po-itogam-9-mesyatsev-2024-goda.

Tinikeyeva A., Nizamdinova A.K. (2021) Sostoyanie i perspektivy razvitiya farmatsevticheskogo marketinga v Kazakhstane [State and prospects of pharmaceutical marketing development in Kazakhstan]. Vestnik KazNPU imeni Abaya. Seriya Ekonomicheskaya, no. 1(67), pp. 32–41.

Gosudarstvennyi reestr lekarstvennykh sredstv i meditsinskikh izdelii Respubliki Kazakhstan [State Register of Medicines and Medical Devices of the Republic of Kazakhstan] [Electronic resource]. Available at: https://register.ndda.kz/.

Grudzinskaya L.M., Gemejiyeva N.G., Karzhaubekova Zh.Zh. The Kazakhstan medicinal flora survey in a leading families volume // Bulletin of Karaganda University. Biology, Medicine, Geography Series. – 2020. – Vol. 100(4). – P. 39–51. https://doi.org/10.31489/2020bmg4/39-51.

Astutik S., Pretzsch J., Kimengsi J.N. Asian medicinal plants’ production and utilization potentials: a review // Sustainability. – 2019. – Vol. 11(19). – Article 5483. https://doi.org/10.3390/su11195483.

Mofokeng M.M., du Plooy C.P., Araya H.T., Amoo S.O., Mokgehle S.N., Pofu K.M., Mashela P.W. Medicinal plant cultivation for sustainable use and commercialisation of high-value crops. South African Journal of Science. 2022;118(7/8). https://doi.org/10.17159/sajs.2022/12190